PRESS RELEASE published on 01/31/2025 at 07:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Poxel annonce les ventes et prévisions de TWYMEEG® au Japon, avec une croissance de 17% au T4 2024 et des ventes prévues à 7,9 milliards de yens pour 2024 Japon Ventes Prévisions Poxel TWYMEEG
BRIEF published on 01/20/2025 at 07:35, 1 year 3 months ago POXEL atteint des ventes majeures avec TWYMEEG® au Japon TWYMEEG® Poxel Sumitomo Pharma Redevances Ventes Japon
BRIEF published on 01/20/2025 at 07:35, 1 year 3 months ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 3 months ago Informations privilégiées / Autres communiqués Poxel annonce l'atteinte des 5 milliards de yens de ventes nettes de TWYMEEG® au Japon, entraînant des redevances croissantes et un paiement basé sur les ventes. Échéances de remboursement et perspective positive Japon Ventes Nettes Poxel TWYMEEG Redevances
PRESS RELEASE published on 01/20/2025 at 07:30, 1 year 3 months ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 1 year 4 months ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
BRIEF published on 12/23/2024 at 07:35, 1 year 4 months ago Poxel publie son rapport financier semestriel pour 2024 Biopharmaceutique Rapport Financier 2024 Poxel Examen D'audit
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 4 months ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Poxel SA announces availability of its 2024 half-year financial report, including condensed financial statements and activities for June 30, 2024 Biopharmaceutical Company Metabolic Disorders MASH 2024 Half-Year Financial Report Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 4 months ago Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel POXEL SA annonce la mise à disposition de son rapport financier semestriel au 30 juin 2024, incluant comptes consolidés, rapport d'activité et attestation Euronext Biopharmaceutique Maladies Métaboliques Rapport Financier Semestriel Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 1 year 4 months ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Published on 05/09/2026 at 01:30, 1 day 17 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 19 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 3 hours 15 minutes ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 5 hours 20 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 7 hours 35 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 22 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
